Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop primatrix supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

PriMatrix: Wound Matrix Guide & FDA Codes

PriMatrix is an acellular fetal bovine dermal matrix. Explore FDA 510(k) clearances, HCPCS Q4110 coding, storage rules, and wound care applications.

Written and maintained by CASRAI Editorial Board

Published

This page describes products and general use; it is not medical advice.

On this page

Short answer

PriMatrix is an acellular dermal repair scaffold derived from fetal bovine dermis, designed to support cellular repopulation and revascularization in chronic and surgical wounds. Cleared by the FDA under 510(k) premarket notifications K061407 and K153690 (product code KGN), it is enriched in embryonic Type III collagen and billed under CMS HCPCS code Q4110 per square centimeter.

Definition and scope

PriMatrix is a sterile, bioabsorbable extracellular matrix (ECM) scaffold manufactured by Integra LifeSciences (originally developed by TEI Biosciences). It is registered under Global Medical Device Nomenclature (GMDN) code 45023 as an animal-derived wound matrix dressing. The matrix is derived exclusively from fetal bovine dermal tissue, providing a natural structural scaffold without artificial chemical cross-linking agents.

In regulatory terms, the United States Food and Drug Administration (FDA) regulates PriMatrix as an Unclassified preamendment medical device under the General and Plastic Surgery panel. Its regulatory standing is established through 510(k) clearances, including K061407 (June 29, 2006) and K153690 (February 22, 2016), under product code KGN (“Dressing, Wound, Collagen” / “Wound Dressing With Animal-Derived Material(S)”). An antimicrobial formulation incorporating ionic silver, PriMatrix Ag, holds clearance under K100261 under product code FRO. Under 21 CFR Part 801 Subpart D, PriMatrix is restricted to prescription use (Rx only) by licensed healthcare practitioners.

The clinical scope of PriMatrix encompasses partial-thickness and full-thickness wounds across acute and chronic presentations. Sourced from FDA-cleared indications, the device is intended for:

  • Diabetic foot ulcers and neuropathic ulcers
  • Venous stasis ulcers and mixed arterial-venous lesions
  • Pressure ulcers (Stage 3 and Stage 4 pressure injuries)
  • Second-degree burns (partial-thickness thermal wounds)
  • Surgical wounds, including post-Mohs micrographic surgery defects, podiatric excisions, donor graft sites, post-laser surgery wounds, and wound dehiscence
  • Trauma wounds, including abrasions, lacerations, and skin tears
  • Tunneled, undermined, and draining wounds

Healthcare facilities managing surgical wound complications can consult surgical wound classification principles to evaluate contamination categories and infection risk factors.

How it works or how it is used in practice

PriMatrix functions as an acellular structural scaffold that mimics native dermal architecture. Because it is sourced from fetal bovine dermis, it possesses an elevated ratio of embryonic Type III collagen alongside Type I collagen. Type III collagen is the primary collagen type produced during early fetal and wound repair phases, facilitating cellular attachment, capillary budding, and dermal fibroblast migration without triggering hyper-inflammatory cross-linked foreign-body reactions.

When placed in contact with viable wound tissue, the scaffold absorbs endogenous blood and interstitial fluid. This promotes the deposition of a fibrin network within its collagen channels, binding endogenous growth factors (such as vascular endothelial growth factor and basic fibroblast growth factor). Host cells progressively populate the matrix, remodeling the scaffold into organized host tissue over several weeks.

In clinical practice, PriMatrix serves as an advanced dermal template applied to thoroughly debrided wound beds. Clinicians secure the scaffold using surgical sutures, staples, or bolster dressings to maintain continuous, intimate contact with viable vascularized tissue. It is managed under secondary dressings, such as a silicone foam wound dressing to regulate exudate, or in tandem with negative pressure wound therapy as outlined in what is a wound vac.

PriMatrix is manufactured in multiple configurations tailored to different anatomical geometries and exudate levels. Clinicians and procurement teams evaluate these alongside broader categories covered in our overview of types of collagen dressing.

Configuration Physical Architecture Clinical Setting Exudate and Drainage Handling Key Differentiator
PriMatrix Standard Solid Sheet Continuous uniform acellular collagen membrane (0.20 mm to 1.04 mm thickness) Flat partial- and full-thickness wounds, clean surgical excisions, donor sites Suited for low to moderate exudate; unperforated sheet retains fluid if drainage surges Provides maximum uniform dermal matrix coverage
PriMatrix Fenestrated Sheet featuring pre-cut linear perforations and slits Moderate-exudate ulcers, diabetic foot ulcers, irregular wound bases Slits allow exudate to pass through into secondary dressings without lifting graft Prevents fluid pooling under the matrix without requiring manual cutting
PriMatrix Meshed Expanded geometric mesh lattice pattern Extensive defects, irregular contours, high-drainage surgical wounds High permeability for heavy exudate drainage; ideal with negative pressure therapy Conforms over undulating anatomical margins and covers expanded surface areas
PriMatrix Ag Antimicrobial Fetal bovine collagen matrix bonded with ionic silver (FDA K100261) Wounds colonized with bacteria or presenting elevated localized infection risk Ionic silver provides broad antimicrobial activity across the scaffold surface Cleared under FDA product code FRO; detailed in what is a collagen silver dressing

Where it matters for labs, clinics or supply decisions

PriMatrix represents an essential inventory category for wound care centers, hospital surgical suites, and tissue-engineering research teams. Procurement and clinical supply coordinators should manage acquisition through a four-point verification framework:

  • Reimbursement and HCPCS Coding: Unlike standard collagen dressings billed under HCPCS A-codes (A6021–A6024), PriMatrix is classified by the Centers for Medicare and Medicaid Services (CMS) as a Cellular and Tissue-Based Product (CTP). It is billed under HCPCS Level II code Q4110 (“Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)”). Reimbursement units correspond directly to the area in square centimeters (cm²) applied, requiring precise defect measurement to avoid wasted units.
  • Storage and Temperature Stability: Sourced from FDA AccessGUDID registry data and manufacturer specifications, PriMatrix is stable at controlled room temperature between 15°C and 30°C (59°F and 86°F). It eliminates the need for expensive -80°C freezers or monitored cold-chain refrigeration required by cellular allografts.
  • Rehydration and Handling Parameters: Manufacturer instructions specify that the dry scaffold must be rehydrated in sterile room-temperature 0.9% sodium chloride saline before placement. Warm saline is strictly contraindicated because thermal exposure denatures collagen triple-helix fibrils. The scaffold must be discarded if shrinkage occurs during hydration.
  • Supplier Vetting: Single-use sterile packaging integrity and verifiable GS1 lot traceability are paramount. Supply teams can consult vetting standards in wound care suppliers to audit vendor compliance and regulatory authenticity.

Common misunderstandings

Common clinical and supply chain misconceptions regarding PriMatrix include:

  • Assuming PriMatrix is derived from adult bovine cattle: Adult bovine dressings primarily feature mature Type I collagen with extensive intermolecular cross-links. PriMatrix is sourced exclusively from fetal bovine dermis, yielding a scaffold naturally rich in Type III embryonic collagen with higher compliance.
  • Believing refrigeration or freezing is necessary: Unlike living cellular allografts, PriMatrix is an acellular lyophilized scaffold that requires only room-temperature shelf storage (15°C to 30°C).
  • Billing under general wound care dressing codes: Submitting PriMatrix claims under generic collagen codes (A6021 or A6022) results in claim rejection. PriMatrix must be billed under CMS code Q4110 per square centimeter.
  • Rehydrating with heated saline or chemical cleansers: Soaking PriMatrix in warmed saline or chemical antiseptics compromises collagen structural integrity. Only sterile room-temperature 0.9% saline is acceptable.
  • Applying PriMatrix on third-degree burns: While indicated for second-degree burns, FDA 510(k) clearances and manufacturer labeling explicitly contraindicate PriMatrix for third-degree (full-thickness) burns.

Frequently asked questions

What is PriMatrix made of?

PriMatrix is derived from acellular fetal bovine dermis. It consists of an uncrosslinked extracellular matrix scaffold enriched in Type I and embryonic Type III collagen, processed to remove non-collagenous cellular elements, lipids, and carbohydrates.

What is the CMS HCPCS billing code for PriMatrix?

PriMatrix is billed under CMS HCPCS Level II code Q4110 (“Primatrix, per square centimeter”). Billing units reflect the surface area in square centimeters (cm²) placed onto the prepared wound bed.

Does PriMatrix require cold-chain storage or refrigeration?

No. PriMatrix is stored at controlled room temperature between 15°C and 30°C (59°F and 86°F). It does not require refrigeration or frozen storage.

What are the primary contraindications for PriMatrix?

PriMatrix is contraindicated in patients with known hypersensitivity to bovine products or collagen, and it is contraindicated for use on third-degree burns.

Sources

  1. U.S. Food and Drug Administration. 510(k) Premarket Notification K061407: PriMatrix Dermal Repair Scaffold. Cleared June 29, 2006. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf6/K061407.pdf (Accessed November 11, 2026).
  2. U.S. Food and Drug Administration. 510(k) Premarket Notification K153690: PriMatrix Dermal Repair Scaffold Labeling Modification. Cleared February 22, 2016. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf15/K153690.pdf (Accessed November 11, 2026).
  3. U.S. Food and Drug Administration. AccessGUDID Unique Device Identification Database: PriMatrix Dermal Repair Scaffold (GMDN 45023, DI 10381780113331). Available from: https://accessdata.fda.gov (Accessed November 11, 2026).
  4. Centers for Medicare and Medicaid Services (CMS). Healthcare Common Procedure Coding System (HCPCS) Level II Code Q4110. Available from: https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system (Accessed November 11, 2026).
  5. Integra LifeSciences. PriMatrix Dermal Repair Scaffold Instructions for Use (IFU). Available from: https://www.integralife.com (Accessed November 11, 2026).

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · full access

Ask about PriMatrix: Wound Matrix Guide & FDA Codes

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →